The Supplement Regulation Gap: FDA, AAFCO, and NASC Explained

Evidence Reviews · July 29, 2026 · 8 min read

Here is a fact that surprises most dog owners: no federal agency reviews or approves your dog’s supplement before it goes on sale. Not the FDA. Not the USDA. Not the FTC (unless advertising claims cross into fraud). The product is manufactured, labeled, and shipped based on the manufacturer’s own assertion that it is safe and accurately represented.

This does not mean the landscape is lawless. Three organizations — the FDA, AAFCO, and NASC — create overlapping layers of oversight. But the layers have gaps, and understanding where those gaps are is essential for any owner making informed purchasing decisions.

The FDA: Limited Jurisdiction, Reactive Enforcement

Legal Framework

Pet supplements fall under the Federal Food, Drug, and Cosmetic Act (FFDCA) as “animal feed” or, in some interpretations, “feed supplements.” They are explicitly not drugs (unless they make disease claims) and not food additives (unless they contain substances not generally recognized as safe).

The FDA’s Center for Veterinary Medicine (CVM) has jurisdiction. But CVM’s resources are allocated primarily to:

• Animal drug approval (new animal drug applications — NADAs)
• Medicated feed regulation
• Food animal safety (residue tolerance, withdrawal periods)
• Pet food safety (contamination, recalls)

Supplements occupy a low-priority enforcement niche. The FDA does not:

• Review supplement formulations before market entry
• Verify label accuracy through routine testing
• Audit manufacturing facilities on a scheduled basis (for supplement-specific operations)
• Maintain a registry of all supplement products on the market

What the FDA Does Enforce

• Illegal drug claims: If a supplement label says “treats arthritis,” “cures cancer,” or “prevents parvovirus,” it is marketed as an unapproved new animal drug. The FDA can issue warning letters, mandate label changes, or pursue product seizure.
• Contamination: Products found to contain heavy metals, mycotoxins, undeclared drugs, or pathogenic bacteria above safety thresholds trigger recall authority.
• Adverse events: The FDA maintains the Safety Reporting Portal for animal supplement adverse events. Reports trigger investigation when patterns emerge.
• Misbranding: Labels that are false or misleading in material respects violate the FFDCA. Enforcement is complaint-driven rather than proactive.

The Practical Reality

The FDA’s supplement enforcement is overwhelmingly reactive. Without an adverse event report, a competitor complaint, or a state referral, a product can remain on the market indefinitely without any federal scrutiny. The agency lacks the budget and mandate for routine supplement surveillance.

AAFCO: Model Regulations, No Enforcement

What AAFCO Is

The Association of American Feed Control Officials is a voluntary, non-governmental organization composed of state and federal feed regulatory officials. It publishes:

• Official Publication (OP): An annual compendium of ingredient definitions, labeling guidelines, and model regulations.
• Ingredient definitions: Standardized descriptions of approved feed ingredients with compositional specifications.
• Labeling models: Guidelines for guaranteed analysis format, ingredient listing order, and nutritional adequacy statements.

What AAFCO Is Not

• AAFCO is not a regulatory agency. It has no inspectors, no enforcement authority, and no penalty mechanism.
• AAFCO does not test products, certify facilities, or issue seals of approval.
• AAFCO does not define or regulate the term “human-grade.”
• AAFCO does not have a specific regulatory category for “supplements” distinct from “feed.”

How AAFCO Models Become Law

Individual states adopt AAFCO model regulations into their own feed control laws. This creates a patchwork:

• Some states adopt AAFCO models verbatim and enforce them actively.
• Some states adopt modified versions.
• Some states have minimal feed regulatory infrastructure.
• Enforcement resources vary enormously by state.

A supplement sold nationally may comply with AAFCO guidelines in one state and face no oversight in another. The manufacturer’s location and the point of sale determine which regulatory regime applies.

AAFCO’s Supplement Relevance

For supplements specifically, AAFCO provides:

• Ingredient definitions that establish what “dried Lactobacillus acidophilus fermentation product” means compositionally.
• Labeling format guidance (guaranteed analysis, ingredient list order).
• Guidance on permissible claims (structure/function vs. drug claims).

But AAFCO does not verify that a product labeled “dried Lactobacillus acidophilus fermentation product” actually contains that ingredient, at that potency, free of contaminants. Verification requires testing, which AAFCO does not perform.

NASC: Voluntary Industry Self-Regulation

What NASC Is

The National Animal Supplement Council is a trade organization founded in 2001 by animal supplement manufacturers. It operates a voluntary quality program with the following components:

• Facility audits: Member manufacturing sites undergo GMP-based audits covering sanitation, documentation, quality control, and personnel training.
• Adverse event reporting (AER): Members must report adverse events to NASC within a defined timeframe. NASC aggregates data and identifies patterns.
• Label review: NASC reviews member product labels for compliance with its labeling guidelines (which align with AAFCO models and FDA expectations).
• Random product testing: NASC conducts periodic blind purchases and laboratory testing of member products for label accuracy and contaminant screening.
• Quality Seal: Products from compliant members may display the NASC Quality Seal.

What the NASC Seal Means

The seal indicates:

• The manufacturer is a NASC member in good standing.
• The manufacturing facility has passed a GMP audit.
• The company participates in adverse event reporting.
• The product label has been reviewed for regulatory compliance.
• The product is subject to random testing.

What the NASC Seal Does NOT Mean

• It does NOT certify product efficacy. NASC does not evaluate whether the product works.
• It does NOT guarantee every batch meets label claims. Testing is random and periodic, not batch-by-batch.
• It does NOT constitute government approval or endorsement.
• It does NOT require clinical evidence for health claims.
• It does NOT cover non-member products (the majority of the market).

Limitations of the NASC Model

• Voluntary participation: Only a fraction of supplement manufacturers are NASC members. Non-members face no NASC oversight.
• Industry-funded: NASC is funded by member dues. This creates an inherent structural incentive to maintain member satisfaction.
• Audit frequency: Audits are periodic (typically every 2-3 years), not continuous. Conditions can change between audits.
• Testing scope: Random testing covers a small percentage of products on the market in any given year.

The Gaps: Where Products Fall Through

Gap 1: No Pre-Market Review

Any entity can formulate a supplement, print a label, and sell it online or in stores without any government review. There is no application, no dossier, no approval step. The first regulatory contact may occur only if something goes wrong.

Gap 2: No Mandatory Batch Testing

Unlike pharmaceutical manufacturing (where every batch undergoes release testing), supplement manufacturers are not required by federal regulation to test every batch for identity, potency, and purity. GMP guidance recommends testing, but enforcement is inconsistent.

Gap 3: No Efficacy Verification

No regulatory body verifies that a supplement does what its label claims. “Supports joint health” is a structure/function claim that requires no evidence submission. The FTC polices advertising claims for deception, but the threshold is “reasonable basis” — not “proven efficacy.”

Gap 4: Limited Post-Market Surveillance

Adverse event reporting for animal supplements is voluntary for owners and veterinarians. The FDA Safety Reporting Portal exists but is underutilized. Without mandatory reporting (as exists for animal drugs), safety signals emerge slowly or not at all.

Gap 5: Online Marketplace Proliferation

Amazon, Chewy, and direct-to-consumer websites enable thousands of supplement products to reach consumers without any retail-level quality gate. Marketplace platforms have limited supplement-specific vetting beyond basic seller verification.

What This Means for Dog Owners

The regulatory gap places the burden of quality assessment on the consumer. In the absence of government pre-approval, owners must evaluate products using available signals:

• NASC membership: Not a guarantee, but indicates participation in a quality framework above the regulatory floor.
• Third-party testing: Independent lab COAs (Certificates of Analysis) for identity, potency, heavy metals, and microbial contamination.
• Transparency: Companies that publish full ingredient sourcing, manufacturing location, and testing protocols demonstrate accountability.
• Clinical evidence: Peer-reviewed studies using the specific product or its key ingredients at included doses.
• Veterinary recommendation: Products recommended by board-certified veterinary nutritionists or internal medicine specialists carry professional vetting.
• Adverse event history: Check the FDA recall database and Safety Reporting Portal for the manufacturer’s track record.

The Bottom Line

The pet supplement market operates in a regulatory space defined more by what is not enforced than by what is. The FDA has authority but limited resources. AAFCO has guidelines but no enforcement power. NASC has a quality program but voluntary participation. The result: a multi-billion-dollar market where product quality ranges from pharmaceutical-grade to negligently manufactured, and the consumer has limited tools to distinguish between them.

This is not an argument against supplements. It is an argument for informed purchasing. The regulatory gap is real. Filling it — for your dog’s sake — requires asking questions, demanding documentation, and rewarding transparency. The companies that welcome scrutiny are the ones worth buying from. The ones that hide behind marketing adjectives are telling you something.